tiprankstipranks
Trending News
More News >
Finch Therapeutics Group (FNCH)
OTHER OTC:FNCH
US Market

Finch Therapeutics Group (FNCH) Financial Statements

Compare
63 Followers

Finch Therapeutics Group Financial Overview

Finch Therapeutics Group's market cap is currently $22.72M. The company's EPS TTM is $; its P/E ratio is ―; Finch Therapeutics Group is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 107.00K$ 861.00K$ 18.53M$ 7.72M$ 10.15M
Gross Profit$ -1.41M$ -4.65M$ -38.75M$ -25.43M$ 9.84M
Operating Income$ -34.00M$ -95.12M$ -59.98M$ -39.44M$ -21.14M
EBITDA$ -32.48M$ -82.69M$ -57.68M$ -38.65M$ -20.66M
Net Income$ -74.75M$ -114.65M$ -58.16M$ -39.25M$ -20.75M
Balance Sheet
Cash & Short-Term Investments$ 25.12M$ 71.04M$ 133.48M$ 99.71M$ 42.19M
Total Assets$ 55.37M$ 162.94M$ 225.37M$ 165.34M$ 103.57M
Total Debt$ 30.13M$ 52.34M$ 6.01M$ 1.81M$ 143.15M
Net Debt$ 5.00M$ -18.70M$ -127.47M$ -97.90M$ 100.96M
Total Liabilities$ 32.49M$ 67.23M$ 23.14M$ 261.06M$ 163.10M
Stockholders' Equity$ 22.89M$ 95.71M$ 202.22M$ -95.72M$ -59.53M
Cash Flow
Free Cash Flow$ -31.50M$ -77.03M$ -83.12M$ -33.96M$ -18.32M
Operating Cash Flow$ -31.50M$ -74.85M$ -67.13M$ -31.33M$ -17.32M
Investing Cash Flow$ 1.33M$ -2.18M$ -15.92M$ -2.63M$ -973.00K
Financing Cash Flow$ -16.16M$ 14.87M$ 119.11M$ 91.47M$ 53.30M
Currency in USD

Finch Therapeutics Group Earnings and Revenue History

Finch Therapeutics Group Debt to Assets

Finch Therapeutics Group Cash Flow

Finch Therapeutics Group Forecast EPS vs Actual EPS